FDA — authorised 31 December 1991
- Application: NDA020105
- Marketing authorisation holder: PH HEALTH
- Local brand name: TRIOSTAT
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Triostat on 31 December 1991
Yes. FDA authorised it on 31 December 1991.
PH HEALTH holds the US marketing authorisation.